Registering new drugs for low-income countries: the African challenge.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 21408102.
- Also identified by DOI 10.1371/journal.pmed.1000411 and PMC identifier 3051317.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Mary Moran and colleagues discuss the best strategies for African regulators to be supported in their efforts to evaluate and approve drugs for their own populations.
Medical subject headings
- Developing Countries
- Drug Approval
- Neglected Diseases
- Registries